1. Introduction {#sec1-ijms-21-04853}
===============

1.1. Polycystic Ovary Syndrome {#sec1dot1-ijms-21-04853}
------------------------------

Polycystic ovary syndrome (PCOS) is a complex endocrinopathy, which affects more than 10% of women of reproductive age \[[@B1-ijms-21-04853]\]. It is the main cause of female infertility due to oligo- or anovulation. Despite such a high incidence, the pathogenesis of PCOS is still unexplained. Some studies suggest that it is due to the genetic factors associated with ovarian steroidogenesis \[[@B2-ijms-21-04853]\]. According to the Androgen Excess and PCOS Society (AE&PCOS), the diagnosis of PCOS should be based on the presence of clinical and/or biochemical hyperandrogenism (HA) and the ovarian dysfunction defined as menstrual abnormalities (anovulatory oligomenorrhea (AnO)) or/and the presence of the polycystic ovary morphology (PCOM) in the transvaginal ultrasound (TV-US) \[[@B3-ijms-21-04853]\]. These criteria yield three separate PCOS phenotypes: A, B, and C. Phenotype A includes all the three features (HA, AnO, and PCOM) whereas phenotype B and C only two (HA and AnO or HA and PCOM, respectively). However, regarding Rotterdam criteria, the fourth phenotype (D) was separated to comprise AnO and PCOM presence. The clinical symptoms of hyperandrogenism include hirsutism (present in 60% of women), androgenic alopecia, and acne, which negatively affect women's psyche, their femininity and lead to low self-esteem and depression \[[@B4-ijms-21-04853]\]. In addition to the reproductive and endocrine dysfunction, PCOS is characterized by intrinsic insulin resistance (IR), which lead to the development of the metabolic syndrome (MetS) and its consequences such as disturbed carbohydrate metabolism and type 2 diabetes mellitus (T2DM). Most common clinical manifestation in PCOS is abdominal obesity, which is involved in the development of dyslipidemia, arterial hypertension (AH), as well as non-alcoholic fatty liver disease (NAFLD) \[[@B5-ijms-21-04853],[@B6-ijms-21-04853],[@B7-ijms-21-04853],[@B8-ijms-21-04853]\]. These in turn lead to the development of cardiovascular disease (CVD), which still remains the main cause of death among women \[[@B9-ijms-21-04853]\]. The clinical picture of this complex endocrinopathy was presented in [Figure 1](#ijms-21-04853-f001){ref-type="fig"}. Therefore, the treatment of PCOS focuses not only on the symptoms of hyperandrogenism and infertility, but also on improving IR and its metabolic consequences \[[@B10-ijms-21-04853]\]. Thus, there is a need for a better understanding of the pathomechanisms of this complex disorder through the identification of potential biomarkers with the use of new, non-invasive and specific methods. In recent years, one of the developing scientific approaches is metabolomics \[[@B11-ijms-21-04853]\].

1.2. Metabolomic Approach in Studying the Pathogenesis of Polycystic Ovary Syndrome {#sec1dot2-ijms-21-04853}
-----------------------------------------------------------------------------------

Among "omics" techniques, metabolomics plays an important role in studying the potential mechanisms responsible for the development of PCOS. Metabolomics allows to identify and quantify small molecules, which occur in all living organisms \[[@B12-ijms-21-04853]\]. The set of all human metabolites that have been identified so far is stored in the Human Metabolome Database (HMDB). Each year, the number of identified metabolites grows. Few years ago, about 41,000 metabolites were found, but now this database contains over 114,190 compounds. Among them, the following groups can be found: amino acids, lipids, peptides, vitamins, organic acids and both endo- and exogenous carbohydrates. Therefore, metabolomics serves as a valuable source of information. The metabolome indicates not only a genetically determined phenotype, but also points to the differences determined by other factors, such as age, diet, or physical activity. The application of metabolomics enables monitoring of the state of an organism and provides information on the compounds formed as a result of many biochemical processes. Any disturbances occurring in a living organism cause changes to the qualitative and quantitative profile of the metabolites. The metabolome describes both the physiological and pathological state of the organism. For this reason, it is known to be an attractive approach, compared to genomics and proteomics, which only suggest the presence of metabolic derangements that occur in the organism \[[@B13-ijms-21-04853],[@B14-ijms-21-04853],[@B15-ijms-21-04853],[@B16-ijms-21-04853]\]. Due to this fact, the use of metabolomics in studying the pathophysiology of PCOS allows to monitor even the smallest biochemical changes in this endocrinopathy and therefore, may help in its diagnosis \[[@B17-ijms-21-04853]\].

Among the many analytical techniques, chromatography coupled with mass spectrometry (MS) seems to be the "gold technique". While chromatography allows for the separation of metabolites present in complex, biological samples, mass spectrometry provides specific information about the chemical structure of the compounds, such as characteristic fragmentation ions, accurate mass, and isotope distribution pattern utilized for the identification of metabolites. MS characterizes very high selectivity and sensitivity that allows to detect and measure trace amounts of metabolites \[[@B18-ijms-21-04853]\]. The combination of MS with gas chromatography (GC-MS) and liquid chromatography (LC-MS) enables to analyse complex biological samples broadly used in metabolomics. GC-MS is suitable for volatile and non-volatile compounds, which require a derivatization step, but first of all thermally stable analytes. The LC-MS technique is widely used for targeted and non-targeted metabolomic analysis and allows to qualify and identify more polar compounds \[[@B19-ijms-21-04853]\]. Nuclear magnetic resonance (NMR), despite its lower sensitivity than MS, allows to analyse metabolites that are difficult to ionize or require derivative reaction for MS and identify compounds with the same masses \[[@B20-ijms-21-04853]\]. A combination of these complementary techniques enables to analyse a broader array of metabolites and offers more certain results than their separate use.

1.3. Matrices for Metabolomic Studies {#sec1dot3-ijms-21-04853}
-------------------------------------

The application of metabolomics allows the use of several matrices such as tissue and body fluids (i.e., plasma, serum, saliva, follicular fluid, semen). The choice of the matrices is associated with the aim of the conducted study as well as the characteristics of the studied disorder. Ovarian tissue can also be used; however, sampling is invasive and problematic. It is usually obtained during laparoscopic wedge resection surgery. For this reason, the use of ovarian tissue in studying the pathophysiology of PCOS is not very common. The matrices widely used in metabolomic studies associated with PCOS are plasma and urine. Serum and urine samples are more common, because they are easily collectible and simple to prepare. On comparing the significantly altered metabolites, it can be observed that the results obtained for both matrices do not completely overlap. The new alternative matrix is follicular fluid, which is innovative in case of PCOS research, especially in terms of oocytes maturation and their quality \[[@B21-ijms-21-04853],[@B22-ijms-21-04853],[@B23-ijms-21-04853]\].

2. Metabolic Alterations in PCOS {#sec2-ijms-21-04853}
================================

PCOS includes a number of abnormalities, which influence several metabolic pathways. It is especially characterized by disturbed metabolism of the steroid hormones, amino acids, carbohydrates, lipids, purines, and the citric acid cycle. Searching for these pathological changes is possible through the metabolomic analyses of biological samples such as serum or plasma, urine, and follicular fluid. Most studies focus on serum and plasma analysis; however, other biological samples also provide substantial information on the existing biochemical derangements. In this review paper, we concentrated on metabolomic studies that were performed in the period of 2014 to 2020 and analysed different biological samples. The PubMed database was searched using the terms "polycystic ovary syndrome" or "PCOS" and "metabolomics". The most important and actual studies using plasma, serum, urine, or FF samples were then analysed.

2.1. Metabolomic Profile Plasma and Serum Samples {#sec2dot1-ijms-21-04853}
-------------------------------------------------

Murri et al. (2014) published a valuable review where they compared few studies based on the analyses of plasma obtained from PCOS women and healthy controls \[[@B11-ijms-21-04853],[@B24-ijms-21-04853],[@B25-ijms-21-04853],[@B26-ijms-21-04853],[@B27-ijms-21-04853]\]. In this paper, we quoted this publication and also presented the results of new studies in this field published since 2014 \[[@B28-ijms-21-04853],[@B29-ijms-21-04853],[@B30-ijms-21-04853],[@B31-ijms-21-04853],[@B32-ijms-21-04853],[@B33-ijms-21-04853],[@B34-ijms-21-04853],[@B35-ijms-21-04853],[@B36-ijms-21-04853],[@B37-ijms-21-04853]\]. A set of metabolites found as the most characteristic for PCOS is presented in [Table 1](#ijms-21-04853-t001){ref-type="table"}. Additionally, information about the applied technique as well as the trend of regulation is included. As can be observed, three metabolic pathways seem to characterise PCOS. Among them, metabolites connected with lipid, amino acid, as well as energy metabolism such as citric acid cycle seem to be the most common. In the case of PCOS, down-regulation of glycerophospholipid metabolism and up-regulation of glucose metabolism was observed. The results published by Zhao et al. (2012) show that all of the determined fatty acids are up-regulated in PCOS compared to the control subjects \[[@B25-ijms-21-04853]\]. A contrary phenomenon occurs in the case of phosphatidylcholine (PC), phosphatidylethanolamine (PE) and its derivatives lysophosphatidylcholine (LPC), lysophosphatidylethanolamine (LPE). Metabolites including PC, PE, LPE, and LPC are decreased. In turn, Fan et al. (2019) observed a decreased level of compounds involved in the metabolism of lecithin \[[@B36-ijms-21-04853]\]. In several studies, androgen metabolism was also taken into account. Three major metabolites connected with elevated androgen metabolism were found, namely dehydroepiandrosterone sulphate (DHEAS), dihydrotestosterone sulphate (DHTS), and androsterone sulphate (ANDS) ([Table 1](#ijms-21-04853-t001){ref-type="table"}). Amino acids (AAs) are the next group of endogenous compounds determined in samples collected from women with PCOS. According to the presented database, there is no homogenous pattern in AAs' regulation. For instance, the levels of arginine, choline, citrulline, glutamate, glycine, and histidine were found to be decreased. In turn, Zhao et al. (2012) reported increased levels of endogenous AAs and glucogenic AAs \[[@B25-ijms-21-04853]\].

2.2. Metabolomic Profile of the Urine Samples {#sec2dot2-ijms-21-04853}
---------------------------------------------

There are relatively few metabolomic studies on PCOS where urine is used as the biological matrix. Urine samples are a convenient study material due to non-invasive sampling as well as easy sample preparation because of the lower content of protein compared to serum and plasma \[[@B38-ijms-21-04853]\]. This matrix is also rich in metabolites of the metabolic pathways, which may be deranged in PCOS. Metabolites, which were down- and up-regulated in women with PCOS compared to healthy controls, are presented in [Table 2](#ijms-21-04853-t002){ref-type="table"} \[[@B39-ijms-21-04853],[@B40-ijms-21-04853],[@B41-ijms-21-04853]\]. Zou et al. (2018) reported that some carbohydrates and fatty acids metabolites are up-regulated in PCOS in comparison with the control subjects \[[@B40-ijms-21-04853]\]. A contrary phenomenon occurs in the case of glycerolipids, where levels of 5 out of 7 compounds are decreased, while up-regulation of triglyceride (TG) and DG (16:1(9Z)/14:0/0:0) was reported. Dhayat et al. (2018) focused on the determination of androgens in PCOS, which were all elevated \[[@B41-ijms-21-04853]\]. A similar trend is reported for AAs, glucocorticoids, and peptides.

2.3. Metabolomic Profile of Follicular Fluid Samples {#sec2dot3-ijms-21-04853}
----------------------------------------------------

Follicular fluid (FF) is an alternative and a useful biological matrix to study the potential mechanism of PCOS pathophysiology. FF is the product of plasma modified by the secretory activity of the granulosa and theca cells \[[@B42-ijms-21-04853]\]. This matrix is collected from women with PCOS undergoing in vitro fertilization. FF contains metabolites essential for oocyte growth and maturation. The analysis of the metabolic derangements in FF samples from women with PCOS allows to understand pathological changes and also disclose the metabolites that could potentially disturb normal oocyte growth \[[@B43-ijms-21-04853]\].

We reviewed a few metabolomic studies that analysed FF from women with PCOS and compared them with healthy controls \[[@B44-ijms-21-04853],[@B45-ijms-21-04853],[@B46-ijms-21-04853],[@B47-ijms-21-04853],[@B48-ijms-21-04853]\]. They were performed with the use of different metabolomic techniques. As can be observed, the concentration of metabolites involved in the TCA cycle, as well as *α*-keto acids, are relatively higher in samples obtained from women with PCOS in comparison with the control subjects. The contrary trend was shown for acylcarnitines. For all of the determined metabolites belonging to acylcarnitines, the decreased level was determined for samples obtained from PCOS patients. However, there are a few metabolic pathways where the trend is not similar among the pathway, but is specific for individual subgroups of compounds. For example, as was reported by Liu et al. (2018), the decreased level of PC was observed in PCOS patients, while the contrary trend (up-regulation) was shown for Lyso PC \[[@B46-ijms-21-04853]\]. In the case of fatty acyls, the general direction demonstrates down-regulation. However, Liu et al. (2018) reported an increased level of 1-Hydroxy-2,12,15-heneicosatrien-4-one in PCOS patients in comparison with the control subjects. The diversity was also observed in the case of AAs metabolism. For example, increased level of phenylalanine, valine, and isoleucine was observed, while a decreased amount of alanine, glutamine, and tyrosine was reported. The results are presented in [Table 3](#ijms-21-04853-t003){ref-type="table"}.

3. Discussion {#sec3-ijms-21-04853}
=============

The summary of all the metabolites detected in three different biological matrices gives us a complementary overview of the metabolomic profile of women with PCOS and allows us to look for a correlation between altered levels of metabolites from different biochemical pathways.

Lipids are the largest group of molecules whose metabolism is deranged in women with PCOS. They are involved in various metabolic pathways, such as steroid hormone biosynthesis, sphingolipid, and fatty acids metabolisms like oxidation or amide metabolism. Phospholipids, which take part in multiple biological pathways, are down-regulated in PCOS. There are few studies confirming the decreased levels of sphinganine, LPE, especially LPE (22:5) and LPC, mainly LPC (18:2) in women with PCOS \[[@B27-ijms-21-04853],[@B28-ijms-21-04853],[@B34-ijms-21-04853]\]. LPCs are involved in glucose metabolism, and low levels of LPC (18:2) correlate with IR and increased risk of T2DM. Thus, this would be in accordance with the observation that women with PCOS are more prone to these metabolic alterations \[[@B34-ijms-21-04853]\]. Hauola et al. (2015) noticed that the differences in the lipid profiles between PCOS and healthy women correlate with the phase of the menstrual cycle. The most significant changes were detected between samples collected from healthy women during the luteal phase of the menstrual cycle and women with PCOS \[[@B35-ijms-21-04853]\]. Among sphingolipids, phytosphingosine (PHS), which stimulates the transcriptional activity of the peroxisome proliferator-activated receptor γ (PPARγ), is downregulated in women with PCOS. According to the literature, PPARs are ligand-dependent transcription factors that regulate the expression of numerous genes associated with the metabolism of carbohydrates, lipids, and proteins \[[@B30-ijms-21-04853]\]. Dysfunction of these receptors may also contribute to the increased risk of MetS and T2DM. The latest lipidomic studies indicate that elevated levels of DG and cholesterol ester, and lower levels of LysoPC correlate with IR, irrespective of a person being overweight or obese \[[@B49-ijms-21-04853]\].

Szczuko et al. (2017) analysed plasma fatty acids in women with PCOS. Their results showed that the levels of all free fatty acids were lower in women with PCOS; however, the concentration of nervonic acid was several times (almost 330 times) higher than in the control subjects. This level of nervonic acid was observed in two analysed groups of women, namely women with PCOS with a biochemical indication of hyperandrogenism and women with normal androgen levels. Poly-unsaturated fatty acids (PUFAs), the precursors of eicosanoids, were significantly increased in women with PCOS compared with the control subjects, which may be due to the presence of low-grade systemic inflammation. In recent years, some studies reported that this process could be stimulated by the pro-inflammatory interleukin-1 (IL-1), which is overexpressed in women with PCOS \[[@B50-ijms-21-04853]\].

One of the detected metabolites, which may be considered as a potential biomarker of PCOS, is DHEA. Excess levels of DHEA are mostly detected in the metabolome of women with PCOS \[[@B29-ijms-21-04853],[@B30-ijms-21-04853],[@B33-ijms-21-04853],[@B34-ijms-21-04853]\]. Serum concentrations of DHEA-S are also evaluated in clinical practice for the evaluation of biochemical hyperandrogenism in women. Besides, 19-oxotestosterone levels are also elevated in women with POCS. This could be due to the higher activity of aromatase, which catalyses the formation of C18 estrogens from C19 androgens \[[@B30-ijms-21-04853]\]. Zhao et al. (2014) showed that, apart from elevated DHEA levels in women with PCOS, there is a significant increase of DHTS and ANDS, which points to the exaggerated androgen synthesis \[[@B29-ijms-21-04853]\]. Dhayat et al. (2018) reported that in women with PCOS, there is an alternative pathway of 11-oxygenated androgen production. They also reported that four steroids such as androstanediol, estriol, 20-β-dihydrocortisone, and cortisol are found as potential markers of PCOS \[[@B41-ijms-21-04853]\].

Lipidomic analysis was also the main goal of the study conducted by Vonica et al. (2019). The authors reported that alterations in acylglycerols, PGs and LTs, phosphocholines, and carnitine metabolites occur in women with PCOS. As a result, cholestane-5α (18:1/0:0), triacylglycerol (18:2/18:2/0-18:0), cholestane-3β, 5α, 6β-triol (18:0/0:0) were found as the crucial metabolites to identify women with PCOS from the controls. Serum levels of these metabolites were decreased. Moreover, elevated acylcarnitine: 2-hydroxylauroylcarnitine with decreased phosphocholines metabolites (18:1/18:4, 18:3/18:2) were also observed. The authors assumed that this alteration might be linked to the lipid peroxidation. Levels of some of the TG (18:2/18:2/0-18:0) and DG species (18:1/20:0/0:0, 18:0/0:0/20:1, 22:4n6/0:0/18:4n3, 18:3/0:0/22:5, 20:0/0:0/20:0, 18:1/24:0/0:0, 18:0/0:0/24:1) were also elevated in women with PCOS in comparison with the control subjects \[[@B37-ijms-21-04853]\]. This can be explained by a higher BMI and increased intra-abdominal fat deposition, which is also a hallmark of PCOS. Dyslipidemia, which occurs in PCOS is characterized by the increased concentrations of total cholesterol (TCh), low density lipoproteins (LDL), very-low density lipoproteins (VLDL), and TGs coupled with decreased high-density lipoproteins (HDL) and HDL-cholesterol. During intestinal absorption, TGs are degraded to fatty acids. After that, they are again resynthesized and transported by the chylomicrons through the bloodstream to the adipose and muscle tissue, where their degradation into free fatty acids and monoacylglycerol takes place. Elevated levels of TGs in PCOS women may be caused by a high fat intake or reduced fat energy consumption at night. It was confirmed that in women with PCOS, the reduced ability to switch to lipid oxidation during fasting also occurs at night \[[@B37-ijms-21-04853]\].

7β-Hydroxycholesterol is another lipid metabolite that could also be a potential biomarker of PCOS. It highly correlates with a PCOS diagnosis. This oxysterol is found as a metabolic intermediate or the end-product of cholesterol metabolism. Due to its bioactivity, it could induce oxidative stress and disturb the metabolism of fatty acids. Chen et al. (2020) showed that elevated levels of 7β-hydroxycholesterol measured in the FF by the induction of the oxidative stress may disturb the growth of oocytes in PCOS \[[@B48-ijms-21-04853]\].

There also are some specific alterations of the bile acid metabolism. These abnormalities and dysfunction of fat absorption in women with PCOS is due to the decreased level of glycocholic acid, which was reported by Zhao et al. (2014) \[[@B29-ijms-21-04853]\] and confirmed by Jia et al. (2019) \[[@B34-ijms-21-04853]\].

The metabolism of prostaglandins and carnitine also seems to be deranged in women with PCOS. Vonica et al. (2019) reported an increased level of the prostaglandin (PG) E2 pathway and oxo-leukotrienes (LT) known to play a pivotal role in inflammation \[[@B37-ijms-21-04853]\]. Dong et al. (2015) showed an increase of prostaglandin F2a (FPG-2a) and a decrease of [l]{.smallcaps}-carnitine in women with PCOS \[[@B30-ijms-21-04853]\]. Elevated levels of FPG-2a may also be related to the presence of a low-grade systemic inflammation in PCOS. In turn, [l]{.smallcaps}-carnitine plays an essential role in fatty acid metabolism as well as their transport across the mitochondrial membrane to the mitochondrial matrix where β-oxidation of fatty acids (FAs) occurs. Decreased levels of [l]{.smallcaps}-carnitine may point to the impairment of these processes in PCOS. It could result in an accumulation of the FAs in the cytosol. It is noticed that [l]{.smallcaps}-carnitine supplementation may improve oocyte quality and therefore, may have a positive effect on fertility \[[@B30-ijms-21-04853]\]. Carnitine is also involved in stabilizing acetylCoA and coenzyme A levels and plays an essential role during fetal maturation \[[@B34-ijms-21-04853]\]. Elevated levels of acetate found by Whigham et al. (2014) and RoyChodhury et al. (2016) also indicate reduced FAs oxidation in women with PCOS \[[@B28-ijms-21-04853]\].

Impaired carbohydrate metabolism is a hallmark of PCOS. Elevated serum lactate and reduced level of glucose determined in plasma samples suggest alterations in glucose metabolism accompanied with elevated glycolytic activity associated with the TCA cycle impairment. Whigham et al. (2014) suggested that in women with PCOS, some AAs are utilized as a source of alternative energy metabolism \[[@B24-ijms-21-04853]\]. Alanine is an important amino acid in the process of gluconeogenesis. Serum alanine-amino transaminase (ALT) activity is elevated in women with PCOS, which usually is the result of NAFLD and lead to increased alanine transformation \[[@B27-ijms-21-04853]\]. According to the literature, ALT is involved in urea cycle and AAs metabolism, where alanine may be converted to pyruvate by donating an amine group and enter the TCA cycle as well as be formed from pyruvate by accepting an amine group, respectively. Serum levels of glucogenic AAs acids such as valine, leucine, and threonine, which may also enter the TCA cycle or be involved in the process of gluconeogenesis were also significantly elevated in women with PCOS. The higher number of growing antral follicles in PCOS utilizes more energy. For this purpose, carbohydrate metabolism may not be sufficient and may thus lead to the utilization of other energy substrates like glutamine, glutamate, or 3-hydroxybutyric acid. Whigham et al. (2014) pointed out that the TCA cycle and glucose metabolism are the major pathways deranged in PCOS \[[@B28-ijms-21-04853]\]. As reported, glucose metabolism can be carried out via alternative pathways such as glycolysis or pentose phosphate pathways and lead to an increased FAs synthesis, which may explain the observed increased FAs accumulation in the adipocytes ([Figure 2](#ijms-21-04853-f002){ref-type="fig"}).

In women with PCOS elevated levels of phenylalanine and glycated phenylalanine were also detected. The accumulation of the glycated AAs was also reported in T2DM \[[@B25-ijms-21-04853]\]. The lower level of other AAs such as proline and histidine may be due to the increased utilization of these AAs as antioxidants during the oxidative stress present in PCOS.

Vitamin B6 metabolism may also be deranged in women with PCOS. One of its metabolic pathways is the synthesis and degradation of the AAs. The results of Chen et al. (2020) showed a significant increase of pyridoxal 5′-phosphate (PLP) and [d]{.smallcaps}-glutamic acid in the FF of women with PCOS. The authors claimed that both compounds are linked with the vitamin B6 metabolism. On the other hand, it is known that PLP is a coenzyme in the metabolism of homocysteine. Moreover, increased levels of homocysteine were observed in women with PCOS. Taking this into the account, disruption of the homocysteine metabolism in PCOS may impair the oocyte microenvironment. The second metabolite detected by the authors was glutamic acid. Its levels are strictly associated with efficiency of the glutamate decarboxylase, while the activity of this enzyme is regulated by the presence of vitamin B6. Glutamic acid is essential for the growth of oocytes, because it can be utilized as an alternative source of energy. These authors also suggested that the increased level of this metabolite is due to its accumulation in the FF \[[@B48-ijms-21-04853]\].

Tang et al. (2019) pointed out that amino acid metabolic abnormalities are also characteristic of PCOS \[[@B51-ijms-21-04853]\]. Among the branched-chain AAs, three were pointed out: valine, leucine, and isoleucine. All of them were up-regulated in women with PCOS. It is assumed that increased levels of valine, leucine, and isoleucine may affect the progression of the IR and obesity. From a biological point of view, branched-chain AAs can serve as substrates for the synthesis of glucose. It occurs in the case of IR, where abnormal glucose metabolism is carried out and alanine is obtained by the transamination of pyruvic acid. Second subgroup of AAs, which are associated with IR are lysine, phenylalanine, and 2-aminoadipic acid. Studies conducted by Tang et al. (2019) pointed to significantly higher concentrations of these metabolites in women with PCOS, which can also be associated with the IR \[[@B51-ijms-21-04853]\]. Chen et al. (2020) reported that phenylalanine may be important for the growth and development of oocytes and could therefore be associated with ovulatory dysfunction \[[@B48-ijms-21-04853]\].

IR plays a key role in the pathophysiology of PCOS and is associated with ovulatory dysfunction and hyperandrogenism. Some mechanisms of IR in women with PCOS are connected to an excessive activity of 17 α-hydroxylase, which regulates the conversion of 17-hydroxyprogesterone into androstenedione, excessive stimulation of IGF-I receptors, and diminished synthesis of insulin-like growth factor binding protein 1 (IGF-BP1) \[[@B52-ijms-21-04853]\].

The Rotterdam diagnostic criteria yield four separate PCOS phenotypes (A, B, C, and D). Phenotype A includes all the three features (HA, AnO, and PCOM), whereas phenotype B, C, and D include only two (HA and AnO or HA and PCOM or AnO and PCOM, respectively). Among the mentioned PCOS studies, only one analyzed the metabolites among four different PCOS phenotypes (A, B, C, and D). Zhao et al. (2012) reported elevated levels of leucine and decreased levels of serine and threonine in women with the C (HA + PCOM) phenotype in comparison to the other phenotypes \[[@B25-ijms-21-04853]\].

Limitations of Metabolomic Studies
----------------------------------

The range of described metabolites identified during metabolomic studies is enormous and gives an overview of the metabolic profile of women with PCOS. Several different compounds and many biochemical pathways seem to be involved in the pathogenesis of PCOS, which indicates the complexity of this common endocrinopathy. These alterations may be caused by an increased or reduced efficiency of different biochemical reactions, up- or down-regulation of genes, increased or decreased activity of enzymes, as well the formation of alternative metabolic pathways. Metabolomics enables us to study these biochemical pathways, which might be involved in the pathogenesis of PCOS. However, it is important to remember that there are some limitations of metabolomic studies. An enormous challenge in research, which is performed with the use of human matrices is inter-individual variability, especially in women, in whom the range of the detected metabolites could be correlated to different hormone levels during the menstrual cycle. Some metabolomic studies were performed relatively in a small group of women, with only tentatively identified metabolites. There could also be some difficulties with the efficiency of the analysers, which sometimes yield false positive results. Furthermore, differences in sample preparation also have a significant impact on the final results.

Therefore, in metabolomics research, every step of the study is significant---from appropriate patient requirements through analytical accuracy to the identification and statistical analysis of the obtained results. That is why there is the need to confirm if the detected compounds could become reliable biomarkers, which would selectively distinguish PCOS from other endocrinopathies.

4. Conclusions {#sec4-ijms-21-04853}
==============

Metabolomics has proven to be a potential tool in studying the pathophysiology of PCOS. The application of metabolomics allows us to discover metabolic pathways that have been shown to be deranged. These abnormalities are associated mainly with the metabolism of lipids, fatty acids, sphingolipids and glycerophospholipids, steroids as well as carbohydrates and amino acids ([Figure 3](#ijms-21-04853-f003){ref-type="fig"}). Additionally, some alternative biochemical processes have been shown to be up-regulated in women with PCOS; however, their clinical significance should be confirmed and evaluated. Determination of disturbed pathways allows identification of the specific compounds characteristic of PCOS, which might be considered as biomarkers and became potential targets for future metabolomic research. Finding appropriate biochemical markers could be a milestone in early diagnosis of this endocrinopathy and a starting point for targeted future pharmacological interventions.
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###### 

The most significant changes in metabolites measured in plasma and serum samples in women with PCOS in comparison with control subjects.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Metabolites                                                PCOS vs. Control                 Metabolic Pathways                             Studies                          Techniques
  ---------------------------------------------------------- -------------------------------- ---------------------------------------------- -------------------------------- ------------
  Cholesterol                                                ↓                                Lipid metabolism                               Zhao et al., 2012                GC-MS\
                                                                                                                                                                              GC-MS

  ↓                                                          Escobar-Morreale et al., 2012                                                                                    

  ↓                                                          Buszewska-Forajta et al., 2019                                                                                   

  Alpha-Tocopherol                                           ↓                                Lipid metabolism                               Escobar-Morreale et al., 2012    GC-MS

  HDL                                                        ↓                                Lipid metabolism                               Zhao et al., 2012                NMR

  Phosphatidylcholine                                        ↓                                Lipid metabolism                               Zhao et al., 2012                NMR

  ↓                                                          Sun et al., 2012                 NMR                                                                             

  Linoleic acid                                              ↑                                Lipid metabolism                               Zhao et al., 2012                GC-MS

  ↑                                                          Dong et al., 2015                LC-MS                                                                           

  Lipoprotein                                                ↑                                Lipid metabolism                               Zhao et al., 2012                NMR

  Palmitic acid                                              ↑                                Lipid metabolism                               Zhao et al., 2012                GC-MS

  C18:0 stearic acid                                         ↑                                Lipid metabolism                               Zhao et al., 2012                GC-MS

  ↓                                                          Szczuko et al., 2017             GC-MS                                                                           

  Unsaturated fatty acid                                     ↑                                Lipid metabolism                               Zhao et al., 2012                NMR

  VLDL/LDL                                                   ↑                                Lipid metabolism                               Zhao et al., 2012                NMR

  Lipid-CH2CH2CO                                             ↓                                Lipid metabolism                               Atiomo et al., 2012              NMR

  ↑                                                          Zhao et al., 2012                NMR                                                                             

  FFA 16:1                                                   ↑                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  FFA 16:2                                                   ↑                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  FFA 18:1                                                   ↑                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  FFA 18:3                                                   ↑                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  FFA 20:1                                                   ↑                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  FFA 20:2                                                   ↑                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  FFA 20:3                                                   ↑                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  FFA 20:4                                                   ↑                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  FFA 20:5                                                   ↑                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  FFA 20:6                                                   ↑                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  FFA 22:5                                                   ↑                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  FFA 22:6                                                   ↑                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  FFA 24:2                                                   ↑                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  MG 18:1                                                    ↑                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  MG 20:3                                                    ↑                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  LPC (16:1)                                                 ↓                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  LPC (16:0)                                                 ↓                                Lipid metabolism                               Haoula et al., 2015              LC-MS

  LPC (18:0)                                                 ↓                                Lipid metabolism                               Haoula et al., 2015              LC-MS

  LPC (18:1)                                                 ↓                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  ↓                                                          Haoula et al., 2015              LC-MS                                                                           

  LPC (18:2)                                                 ↓                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  ↓                                                          Dong et al., 2015                LC-MS                                                                           

  ↓                                                          Jia et al., 2019                 LC-MS                                                                           

  ↑                                                          Buszewska-Forajta et al., 2019   LC-MS                                                                           

  ↓                                                          Haoula et al., 2015              LC-MS                                                                           

  LPC 18:3                                                   ↓                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  ↓                                                          Dong et al., 2015                LC-MS                                                                           

  LPC 20:5                                                   ↓                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  LPC 22:5                                                   ↓                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  LPE 16:0                                                   ↓                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  LPE 18:1                                                   ↓                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  LPE 18:2                                                   ↓                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  LPE 20:4                                                   ↓                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  LPE 22:5                                                   ↓                                Lipid metabolism                               Zhao et al., 2014                LC-MS

  ↓                                                          Dong et al., 2015                LC-MS                                                                           

  ↓                                                          Jia et al., 2019                 LC-MS                                                                           

  PC (18:1/18:4)                                             ↓                                Lipid metabolism                               Vonica et al., 2019              LC-MS

  PC (18:3/18:2)                                             ↓                                Lipid metabolism                               Vonica et al., 2019              LC-MS

  PC (32:4)                                                  ↓                                Lipid metabolism                               Haoula et al., 2015              LC-MS

  PC (30:0)                                                  ↓                                Lipid metabolism                               Haoula et al., 2015              LC-MS

  PE (42:1)                                                  ↓                                Lipid metabolism                               Haoula et al., 2015              LC-MS

  PE (34:0)                                                  ↓                                Lipid metabolism                               Haoula et al., 2015              LC-MS

  SM (d18:0/20:2)                                            ↑                                Lipid metabolism                               Haoula et al., 2015              LC-MS

  SM (d18:0/18:0)                                            ↑                                Lipid metabolism                               Haoula et al., 2015              LC-MS

  Triglycerides                                              ↑                                Lipid metabolism                               Haoula et al., 2015              LC-MS

  DG (36:2)                                                  ↑                                Lipid metabolism                               Haoula et al., 2015              LC-MS

  DG (36:3)                                                  ↑                                Lipid metabolism                               Haoula et al., 2015              LC-MS

  Plasmalogen (30:0)                                         ↓                                Lipid metabolism                               Haoula et al., 2015              LC-MS

  Plasmalogen (40:7)                                         ↑                                Lipid metabolism                               Haoula et al., 2015              LC-MS

  Azelaic acid                                               ↑                                Lipid metabolism                               Dong et al., 2015                LC-MS

  N-undecanoylglycine                                        ↑                                Lipid metabolism                               Dong et al., 2015                LC-MS

  Chenodeoxycholic acid                                      ↑                                Lipid metabolism                               Fan et al., 2019                 LC-MS

  Cholic acid                                                ↓                                Lipid metabolism                               Fan et al., 2019                 LC-MS

  Clupanodonylcarnitine                                      ↑                                Lipid metabolism                               Fan et al., 2019                 LC-MS

  2-Hydroxylauroylcarnitine                                  ↑                                Lipid metabolism                               Vonica et al., 2019              LC-MS

  Trans-2-dodecenoylcarnitine                                ↑                                Lipid metabolism                               Vonica et al., 2019              LC-MS

  Cholestane-3β                                              ↑                                Sterol lipid metabolism                        Vonica et al., 2019              LC-MS

  Cholestane-5α (18:0/0:0)                                   ↑                                Sterol lipid metabolism                        Vonica et al., 2019              LC-MS

  Cholestane-6β-triol                                        ↑                                Sterol lipid metabolism                        Vonica et al., 2019              LC-MS

  Cholestane (18:1/0:0)                                      ↑                                Sterol lipid metabolism                        Vonica et al., 2019              LC-MS

  Androsterone sulphate                                      ↑                                Lipid transport and metabolism                 Fan et al., 2019                 LC-MS

  11′-Carboxy-α-chromanol                                    ↑                                Lipid transport and metabolism                 Fan et al., 2019                 LC-MS

  (9-cis,9′-cis)-7,7′,8,8′-Tetrahydro-y,y-Carotene           ↑                                Lipid transport and metabolism                 Fan et al., 2019                 LC-MS

  Sphinganine                                                ↓                                Sphingolipid metabolism                        Dong et al., 2015                LC-MS

  ↓                                                          Jia et al., 2019                 LC-MS                                                                           

  ↑                                                          Buszewska-Forajta et al., 2019   LC-MS                                                                           

  Phytosphingosine                                           ↓                                Sphingolipid metabolism                        Dong et al., 2015                LC-MS

  Palmitoylsphingomyelin                                     ↑                                Sphingomyelin metabolism                       Fan et al., 2019                 LC-MS

  SM (d18:1/16:0)                                            ↑                                Sphingomyelin metabolism                       Fan et al., 2019                 LC-MS

  LysoPC (O-18:0)                                            ↓                                Lecithin metabolism                            Fan et al., 2019                 LC-MS

  LysoPC (16:0)                                              ↓                                Lecithin metabolism                            Fan et al., 2019                 LC-MS

  LysoPC \[20:2(11Z,14Z)\]                                   ↓                                Lecithin metabolism                            Fan et al., 2019                 LC-MS

  Glyceric acid                                              ↑                                Glycerolipid metabolism                        Dong et al., 2015                LC-MS

  LPC (20:2)                                                 ↓                                Glycerophospholipid metabolism                 Dong et al., 2015                LC-MS

  2-Arachidonoyl                                             ↑                                Glycerophospholipid metabolism                 Fan et al., 2019                 LC-MS

  glycerophosphocholine                                                                                                                                                       

  PG \[18:1(9Z)/16:0\]                                       ↓                                Glycerophospholipid metabolism                 Fan et al., 2019                 LC-MS

  PE \[O-18:1(1Z)/20:4\                                      ↓                                Glycerophospholipid metabolism                 Fan et al., 2019                 LC-MS
  (5Z,8Z,11Z,14Z)\]                                                                                                                                                           

  LysoPE \[0:0/22:1(13Z)\]                                   ↓                                Glycerophospholipid metabolism                 Fan et al., 2019                 LC-MS

  PE \[O-16:1(1Z)/22:6\                                      ↓                                Glycerophospholipid metabolism                 Fan et al., 2019                 LC-MS
  (4Z,7Z,10Z,13Z,16Z,19Z)\]                                                                                                                                                   

  PE \[22:4(7Z,10Z,13Z,16Z)/16:0\]                           ↓                                Glycerophospholipid metabolism                 Fan et al., 2019                 LC-MS

  PC \[16:1(9Z)/22:2(13Z,16Z)\]                              ↓                                Glycerophospholipid metabolism                 Fan et al., 2019                 LC-MS

  PG (18:0/16:0)                                             ↑                                Glycerophospholipid metabolism                 Fan et al., 2019                 LC-MS

  PG (18:1(9Z)/18:0)                                         ↓                                Glycerophospholipid metabolism                 Fan et al., 2019                 LC-MS

  DG (18:1n9/0:0/20:4n3)                                     ↑                                Diacyloglycerol metabolism                     Fan et al., 2019                 LC-MS

  TG (18:2/18:2/0-18:0)                                      ↑                                Diacyloglycerol metabolism                     Vonica et al., 2019              LC-MS

  DG (22:2/0:0/22:4)                                         ↓                                Diacyloglycerol metabolism                     Vonica et al., 2019              LC-MS

  Arginine                                                   ↓                                Amino acids metabolism                         Atiomo et al., 2012              NMR

  ↓                                                          Sun et al., 2012                 NMR                                                                             

  Choline                                                    ↓                                Amino acids metabolism                         Sun et al., 2012                 NMR

  Citruline                                                  ↓                                Amino acids metabolism                         Atiomo et al., 2012              NMR

  Glutamate                                                  ↓                                Amino acids metabolism                         Atiomo et al., 2012              NMR

  Glycerophosphocholine/phosphocholine                       ↓                                Amino acids metabolism                         Sun et al., 2012                 NMR

  Glycine                                                    ↓                                Amino acids metabolism                         Zhao et al., 2012                GC-MS

  Histidine                                                  ↓                                Amino acids metabolism                         Atiomo et al., 2012              NMR

  ↓                                                          RoyChoudhury et al., 2016                                                                                        

  AAA                                                        ↑                                Amino acids metabolism                         Zhao et al., 2012                GC-MS

  BCAA                                                       ↑                                Amino acids metabolism                         Zhao et al., 2012                GC-MS

  BCAA/AAA                                                   ↓                                Amino acids metabolism                         Zhao et al., 2012                GC-MS

  Aspartate                                                  ↑                                Amino acids metabolism                         Zhao et al., 2012                GC-MS

  Endogenous AAs                                             ↑                                Amino acids metabolism                         Zhao et al., 2012                GC-MS

  Gluconeogenic AAs                                          ↑                                Amino acids metabolism                         Zhao et al., 2012                GC-MS

  Serine                                                     ↑                                Amino acids metabolism                         Zhao et al., 2012                GC-MS

  2-Aminobutyrate                                            ↑                                Amino acid metabolism                          Whigham et al., 2014             NMR

  2-Hydroxybutyrate                                          ↑                                Amino acid metabolism                          Whigham et al., 2014             NMR

  2-Hyroxyisovalerate                                        ↑                                Amino acid metabolism                          Whigham et al., 2014             NMR

  2-Oxocaproate                                              ↑                                Amino acid metabolism                          Whigham et al., 2014             NMR

  2-Oxoisocaproate                                           ↑                                Amino acid metabolism                          Whigham et al., 2014             NMR

  3-Hydroxybutyrate                                          ↑                                Amino acid metabolism                          Whigham et al., 2014             NMR

  3-Methyl-2-oxovalerate                                     ↑                                Amino acid metabolism                          Whigham et al., 2014             NMR

  Betadine                                                   ↑                                Amino acid metabolism                          Whigham et al., 2014             NMR

  Creatinine                                                 ↑                                Amino acid metabolism                          Whigham et al., 2014             NMR

  ↓                                                          Sun et al., 2012                 NMR                                                                             

  Dimethylamine                                              ↑                                Amino acid metabolism                          Whigham et al., 2014             NMR

  Lysine                                                     ↑                                Amino acid metabolism                          Whigham et al., 2014             NMR

  ↑                                                          Zhao et al., 2012                GC-MS                                                                           

  ↓                                                          Atiomo et al., 2012              NMR                                                                             

  Methionine                                                 ↑                                Amino acid metabolism                          Whigham et al., 2014             NMR

  ↓                                                          Sun et al., 2012                 NMR                                                                             

  Ornithine                                                  ↑                                Amino acid metabolism                          Whigham et al., 2014             NMR

  ↑                                                          Zhao et al., 2012                GC-MS                                                                           

  ↓                                                          Atiomo et al., 2012              NMR                                                                             

  Sarcosine                                                  ↑                                Amino acid metabolism                          Whigham et al., 2014             NMR

  Taurine                                                    ↑                                Amino acid metabolism                          Whigham et al., 2014             NMR

  Tryptophan                                                 ↑                                Amino acid metabolism                          Whigham et al., 2014             NMR

  ↑                                                          Zhao et al., 2012                GC-MS                                                                           

  ↑                                                          Buszewska-Forajta et al., 2019   GC/LC-MS                                                                        

  Tyrosine                                                   ↑                                Amino acid metabolism                          Whigham et al., 2014             NMR

  ↑                                                          Zhao et al., 2012                GC-MS                                                                           

  ↑                                                          Buszewska-Forajta et al., 2019   GC-MS                                                                           

  Glutamate                                                  ↓                                Amino acids metabolism                         RoyChoudhury et al., 2016        NMR

  ↑                                                          Whigham et al., 2014             NMR                                                                             

  Glutamine                                                  ↓                                Amino acids metabolism                         RoyChoudhury et al., 2016        NMR

  ↑                                                          Whigham et al., 2014             NMR                                                                             

  ↓                                                          Sun et al., 2012                 NMR                                                                             

  Proline                                                    ↓                                Amino acids metabolism                         Atiomo et al., 2012              NMR

  ↓                                                          Zhao et al., 2012                GC-MS                                                                           

  ↓                                                          RoyChoudhury et al., 2016        NMR                                                                             

  ↑                                                          Whigham et al., 2014             NMR                                                                             

  Alanine                                                    ↑                                Amino acids metabolism                         RoyChoudhury et al., 2016        NMR

  ↑                                                          Whigham et al., 2014             NMR                                                                             

  ↑                                                          Zhao et al., 2012                NMR                                                                             

  ↓                                                          Escobar-Morreale et al., 2012    GC-MS                                                                           

  Leucine                                                    ↑                                Amino acids metabolism                         RoyChoudhury et al., 2016        NMR

  ↑                                                          Whigham et al., 2014             NMR                                                                             

  ↓                                                          Sun et al., 2012                 NMR                                                                             

  ↑                                                          Zhao et al., 2012                GC-MS                                                                           

  Isoleucine                                                 ↑                                Amino acids metabolism                         Whigham et al., 2014             NMR

  ↓                                                          Zhao et al., 2012                GC-MS                                                                           

  Valine                                                     ↑                                Amino acids metabolism                         RoyChoudhury et al., 2016        NMR

  ↑                                                          Whigham et al., 2014             NMR                                                                             

  ↑                                                          Zhao et al., 2012                GC-MS                                                                           

  Threonine                                                  ↑                                Amino acids metabolism                         RoyChoudhury et al., 2016        NMR

  ↑                                                          Whigham et al., 2014             NMR                                                                             

  ↑                                                          Zhao et al., 2012                GC-MS                                                                           

  ↑                                                          Buszewska-Forajta et al., 2019   GC-MS                                                                           

  Cysteine-S-sulphate                                        ↑                                Amino acid metabolism                          Fan et al., 2019                 LC-MS

  Glu-Glu                                                    ↑                                Amino acid metabolism                          Dong et al., 2015                LC-MS

  Asparagine                                                 ↑                                Amino acid metabolism                          Whigham et al., 2014             NMR

  Ketoleucine                                                ↓                                Valine, leucine, and isoleucine degradation    Dong et al., 2015                LC-MS

  Glutamic acidc                                             ↑                                Glutamate metabolism, amino sugar metabolism   Dong et al., 2015                LC-MS

  Phenylpyruvic acid                                         ↑                                Phenylalanine and tyrosine metabolism          Dong et al., 2015                LC-MS

  Gly.Phe                                                    ↑                                Phenylalanine and tyrosine metabolism          Zhao et al., 2014                LC-MS

  Phenylalanine                                              ↑                                Phenylalanine and tyrosine metabolism          Zhao et al., 2014                LC-MS

  ↑                                                          Whigham et al., 2014             NMR                                                                             

  ↑                                                          Zhao et al., 2012                GC-MS                                                                           

  ↑                                                          Buszewska-Forajta et al., 2019   GC-MS                                                                           

  Phe−Phe                                                    ↑                                Phenylalanine and tyrosine metabolism          Zhao et al., 2014                LC-MS

  Kynurenine                                                 ↓                                Tryptophan metabolism                          Zhao et al., 2014                LC-MS

  5-Hydroxyindoleacetic acid                                 ↓                                Tryptophan metabolism                          Dong et al., 2015                LC-MS

  Homoserine                                                 ↓                                Methionine metabolism                          Zhao et al., 2014                LC-MS

  ↑                                                          Whigham et al., 2014             NMR                                                                             

  S-Adenosylmethionine                                       ↓                                Thiol amino acid metabolic cycle               Fan et al., 2019                 LC-MS

  Pyroglutamic acid                                          ↑                                Glutathione metabolism                         Dong et al., 2015                LC-MS

  Lysyl-albumin                                              ↓                                Protein metabolism                             Zhao et al., 2012                NMR

  Trimethylamine N-oxide                                     ↓                                Protein metabolism                             Sun et al., 2012                 NMR

  2-Ketoisocaproic acid                                      ↓                                Protein metabolism                             Escobar-Morreale et al., 2012    GC-MS

  Dimethylamine                                              ↑                                Protein metabolism                             Sun et al., 2012                 NMR

  *N*-acetylglycoprotein                                     ↓                                Protein metabolism                             Zhao et al., 2012                NMR

  ↑                                                          Sun et al., 2012                 NMR                                                                             

  Hypoxanthine                                               ↑                                Purine metabolism                              Zhao et al., 2014                LC-MS

  Inosine                                                    ↑                                Purine metabolism                              Zhao et al., 2014                LC-MS

  Allantoic acid                                             ↑                                Purine metabolism                              Dong et al., 2015                LC-MS

  Uric acid                                                  ↑                                Purine metabolism                              Zhao et al., 2012                GC-MS

  ↑                                                          Buszewska-Forajta et al., 2019   GC/LC-MS                                                                        

  Cyclic GMP                                                 ↑                                Purine metabolism                              Fan et al., 2019                 LC-MS

  Uridine                                                    ↓                                Pyrimidine metabolism                          Zhao et al., 2014                LC-MS

  ↓                                                          Dong et al., 2015                LC-MS                                                                           

  5,6-Dihydrouridine                                         ↑                                Pyrimidine metabolic cycle                     Fan et al., 2019                 LC-MS

  DHEAS                                                      ↑                                Androgen metabolism                            Zhao et al., 2014                LC-MS

  ↑                                                          Dong et al., 2015                LC-MS                                                                           

  ↑                                                          Buszewska-Forajta et al., 2019   LC-MS                                                                           

  ↑                                                          Jia et al., 2019                 LC-MS                                                                           

  ↑                                                          Fan et al., 2019                 LC-MS                                                                           

  ANDS                                                       ↑                                Androgen metabolism                            Zhao et al., 2014                LC-MS

  DHTS                                                       ↑                                Androgen metabolism                            Zhao et al., 2014                LC-MS

  Pregnenolone sulphate                                      ↓                                Steroid hormone biosynthesis                   Dong et al., 2015                LC-MS

  19-Oxotestosterone                                         ↑                                Steroid hormone biosynthesis                   Dong et al., 2015                LC-MS

  C10:0 lauric acid                                          ↓                                Fatty acid metabolism                          Szczuko et al., 2017             GC-MS

  C15:0 pentadecanoic acid                                   ↓                                Fatty acid metabolism                          Szczuko et al., 2017             GC-MS

  C15:1 cis-10-pentadecanoic acid                            ↓                                Fatty acid metabolism                          Szczuko et al., 2017             GC-MS

  C17:0 heptadecanoic acid                                   ↓                                Fatty acid metabolism                          Szczuko et al., 2017             GC-MS

  C20:0 arachidic acid                                       ↓                                Fatty acid metabolism                          Szczuko et al., 2017             GC-MS

  C20:1 cis-11-eicosanoic acid                               ↑                                Fatty acid metabolism                          Szczuko et al., 2017             GC-MS

  C22:5 EPA                                                  ↓                                Fatty acid metabolism                          Szczuko et al., 2017             GC-MS

  C22:0 behenic acid                                         ↓                                Fatty acid metabolism                          Szczuko et al., 2017             GC-MS

  C23:0 tricosanoic acid                                     ↓                                Fatty acid metabolism                          Szczuko et al., 2017             GC-MS

  C22:4n6 docosatetraenic acid                               ↑                                Fatty acid metabolism                          Szczuko et al., 2017             GC-MS

  C24:0 lignoceric acid                                      ↓                                Fatty acid metabolism                          Szczuko et al., 2017             GC-MS

  C24:1 nervonic acid                                        ↑                                Fatty acid metabolism                          Szczuko et al., 2017             GC-MS

  9-HODE/13-HODE                                             ↑                                Fatty acid metabolism                          Dong et al., 2015                LC-MS

  α-Linolenic acid                                           ↑                                Fatty acid metabolism                          Dong et al., 2015                LC-MS

  C18:2n6c linoleic acid                                     ↓                                Fatty acid metabolism                          Szczuko et al., 2017             GC-MS

  Vaccenic acid                                              ↑                                Fatty acid metabolism                          Dong et al., 2015                LC-MS

  Docosatrienoic acid                                        ↑                                Fatty acid metabolism                          Dong et al., 2015                LC-MS

  Eicosapentaenoic acid                                      ↑                                Fatty acid metabolism                          Dong et al., 2015                LC-MS

  Galbanic acid                                              ↑                                Fatty acid metabolism                          Fan et al., 2019                 LC-MS

  C14:0 myristic acid                                        ↑                                Fatty acid biosynthesis                        Dong et al., 2015                LC-MS

  ↓                                                          Szczuko et al., 2017             GC-MS                                                                           

  Palmitoleic acid                                           ↑                                Fatty acid biosynthesis                        Dong et al., 2015                LC-MS

  Palmitoleoylethanolamide                                   ↑                                Fatty acid amide metabolism                    Dong et al., 2015                LC-MS

  Oleamide                                                   ↑                                Fatty acid amide metabolism                    Zhao et al., 2014                LC-MS

  ↑                                                          Dong et al., 2015                LC-MS                                                                           

  Palmitic amide                                             ↑                                Fatty acid amide metabolism                    Zhao et al., 2014                LC-MS

  ↑                                                          Dong et al., 2015                LC-MS                                                                           

  PEA                                                        ↑                                Fatty acid amide metabolism                    Zhao et al., 2014                LC-MS

  AEA                                                        ↑                                Fatty acid amide metabolism                    Zhao et al., 2014                LC-MS

  Carnitine C2:0                                             ↑                                Beta oxidation of fatty acids                  Zhao et al., 2014                LC-MS

  Carnitine C6:0                                             ↑                                Beta oxidation of fatty acids                  Zhao et al., 2014                LC-MS

  Carnitine C18                                              ↑                                Beta oxidation of fatty acids                  Zhao et al., 2014                LC-MS

  Carnitine                                                  ↓                                Oxidation of fatty acids                       Dong et al., 2015                LC-MS

  ↓                                                          Jia et al., 2019                 LC-MS                                                                           

  Glycocholic acid                                           ↓                                Bile acid metabolism                           Zhao et al., 2014                LC-MS

  ↓                                                          Jia et al., 2019                 LC-MS                                                                           

  3,7-Dihydroxy-5-cholestenoic acid                          ↑                                Bile acid metabolism                           Fan et al., 2019                 LC-MS

  3-β-Hydroxy-4-β-methyl-5-α-cholest-7-ene-4-α-carboxylate   ↑                                Bile acid metabolism                           Fan et al., 2019                 LC-MS

  Formate                                                    ↑                                Pyruvate metabolism                            Whigham et al., 2014             NMR

  Fructose                                                   ↑                                Pyruvate metabolism                            Whigham et al., 2014             NMR

  Mannose                                                    ↑                                Pyruvate metabolism                            Whigham et al., 2014             NMR

  Citrate                                                    ↓                                TCA cycle metabolism                           Whigham et al., 2014             NMR

  ↓                                                          Atiomo et al., 2012              NMR                                                                             

  ↓                                                          Sun et al., 2012                 NMR                                                                             

  Acetate                                                    ↑                                TCA cycle metabolism                           RoyChoudhury et al., 2016        NMR

  ↑                                                          Whigham et al., 2014             NMR                                                                             

  4a-Methylzymosterol-4-carboxylic acid                      ↑                                TCA cycle metabolism                           Fan et al., 2019                 LC-MS

  Lactate                                                    ↑                                Gluconeogenesis/Glycolysis                     RoyChoudhury et al., 2016        NMR

  ↑                                                          Whigham et al., 2014             NMR                                                                             

  ↑                                                          Zhao et al., 2012                GC-MS/                                                                          

                                                                                              NMR                                                                             

  Lactic acid                                                ↑                                Gluconeogenesis/Glycolysis                     Buszewska-Forajta et al., 2019   GC-MS

  Gluconolactone                                             ↑                                Pentose phosphate pathway                      Dong et al., 2015                LC-MS

  3-Hydroxybutyric acid                                      ↓                                Energy metabolism                              RoyChoudhury et al., 2016        NMR

  Glucose                                                    ↓                                Energy metabolism                              RoyChoudhury et al., 2016        NMR

  ↓                                                          Zhao et al., 2012                GC-MS                                                                           

  ↑                                                          Whigham et al., 2014             /NMR                                                                            

                                                                                              NMR                                                                             

  Glyceraldehyde 3-phosphate                                 ↑                                ATP metabolism                                 Fan et al., 2019                 LC-MS

  Glycerol                                                   ↓                                Glucose metabolism                             Whigham et al., 2014             NMR

  Acetoacetate                                               ↑                                Glucose metabolism                             Whigham et al., 2014             NMR

  Pyruvate                                                   ↑                                Glucose metabolism                             Whigham et al., 2014             NMR

  Acetone                                                    ↑                                Glucose metabolism                             Whigham et al., 2014             NMR

  ↓                                                          Atiomo et al., 2012              NMR                                                                             

  Fructose 6-phosphate                                       ↓                                Amino sugar metabolism                         Dong et al., 2015                LC-MS

  Aspartic acid                                              ↑                                Aspartate metabolism                           Zhao et al., 2014                LC-MS

  Thyroxine sulphate                                         ↓                                ATP metabolism                                 Fan et al., 2019                 LC-MS

  Pantothenic acid                                           ↑                                Pantothenate and CoA biosynthesis              Dong et al., 2015                LC-MS

  Prostaglandin F2a                                          ↑                                Arachidonic acid metabolism                    Dong et al., 2015                LC-MS

  ↑                                                          Vonica et al., 2019              LC-MS                                                                           

  25-Methyl-1-hexacosanol                                    ↓                                Fatty alcohols                                 Fan et al., 2019                 LC-MS

  S-(PGJ2)---glutathione                                     ↑                                Immune modulation                              Fan et al., 2019                 LC-MS

  Oryzanol A                                                 ↓                                Endocrine modulation                           Fan et al., 2019                 LC-MS
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

HDL = high-density lipoproteins, VLDL/LDL = very-low density lipoproteins/ low density lipoproteins, FFA = free fatty acid, PC = phosphatidylcholine, PE = phosphatidylethanolamine, LPC (LysoPC) = lysophosphatidylcholine, LPE = lysophospha-tidylethanolamine, SM = sphingomyelin, DG = diglyceride, TG = trigliceride, PG = phosphatidylglycerol, AAA = aromatic amino acids, BCAA = branched-chain amino acid, AAs = amino acid, GMP = guanosine monophosphate, DHEAS = dehydro-epiandrosterone sulphate, ANDS = androsterone sulphate, DHTS = dihydrotestosterone sulphate, EPA = eicosapentaenoic acid, HODE = hydroxyoctadecadienoic acid, PEA = palmitoylethanolamide, AEA = N-arachidonoylethanolamine; ↑ up-regulation; ↓ down-regulation.
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The most significant changes in urinary metabolites in women with PCOS in comparison with the control subjects.

  Metabolites                             PCOS vs. Control   Metabolic Pathways          Studies               Techniques
  --------------------------------------- ------------------ --------------------------- --------------------- ------------
  Lactose                                 ↑                  Carbohydrate metabolism     Zou et al., 2018      GC-MS
  Gluconic acid                           ↑                  Carbohydrate metabolism     Zou et al., 2018      GC-MS
  3-hydroxypropionic acid                 ↑                  Carbohydrate metabolism     Zou et al., 2018      GC-MS
  Arabinitol                              ↑                  Carbohydrate metabolism     Zou et al., 2018      GC-MS
  Fucose                                  ↑                  Carbohydrate metabolism     Zou et al., 2018      GC-MS
  Oxalic acid                             ↑                  Carbohydrate metabolism     Zou et al., 2018      GC-MS
  Arabic candy                            ↑                  Lipid metabolism            Zou et al., 2018      GC-MS
  Stearic acid                            ↑                  Lipid metabolism            Zou et al., 2018      GC-MS
  Palmitic acid                           ↑                  Lipid metabolism            Zou et al., 2018      GC-MS
  Phosphoethanolamine                     ↑                  Lipid metabolism            Zou et al., 2018      GC-MS
  2-(14,15-Epoxyeicosatrienoyl)           ↓                  Glycerolipids               Wang et al., 2015     LC-MS
  TG (14:1(9Z)/14:0/22:2(13Z,16Z))        ↓                  Glycerolipids               Wang et al., 2015     LC-MS
  TG (14:0/24:1(15Z)/14:1(9Z))            ↓                  Glycerolipids               Wang et al., 2015     LC-MS
  TG(16:0/14:0/18:0)                      ↓                  Glycerolipids               Wang et al., 2015     LC-MS
  TG (16:0/14:1(9Z)/20:1(11Z))            ↓                  Glycerolipids               Wang et al., 2015     LC-MS
  TG                                      ↑                  Glycerolipids               Wang et al., 2015     LC-MS
  DG (16:1(9Z)/14:0/0:0)                  ↑                  Glycerolipids               Wang et al., 2015     LC-MS
  PC (22:2(13Z,16Z)/18:1(9Z))             ↓                  Glycerophospholipids        Wang et al., 2015     LC-MS
  PC (14:1(9Z)/14:1(9Z))                  ↓                  Glycerophospholipids        Wang et al., 2015     LC-MS
  LPA (16:0/0:0)                          ↓                  Glycerophospholipids        Wang et al., 2015     LC-MS
  PE (14:1(9Z)/14:1(9Z))                  ↑                  Glycerophospholipids        Wang et al., 2015     LC-MS
  LysoPC (18:1(9Z))                       ↑                  Glycerophospholipids        Wang et al., 2015     LC-MS
  Cer (d18:0/20:0)                        ↓                  Sphingolipids               Wang et al., 2015     LC-MS
  Phytosphingosine                        ↓                  Sphingolipids               Wang et al., 2015     LC-MS
  Glycocholic acid                        ↓                  Steroids                    Wang et al., 2015     LC-MS
  Chenodeoxycholic acid 3-sulphate        ↓                  Steroids                    Wang et al., 2015     LC-MS
  3-Oxo-4,6-choladienoic acid             ↓                  Steroids                    Wang et al., 2015     LC-MS
  Cortolone-3-glucuronide                 ↑                  Steroids                    Wang et al., 2015     LC-MS
  11α-Hydroxyprogesterone                 ↑                  Steroids                    Wang et al., 2015     LC-MS
  Testosterone glucuronide                ↑                  Steroids                    Wang et al., 2015     LC-MS
  Tetrahydroaldosterone-3-glucuronide     ↑                  Steroids                    Wang et al., 2015     LC-MS
  Dehydroepiandrosterone                  ↑                  Androgen metabolism         Dhayat et al., 2018   GC-MS
  16α-OH-dehydroepiandrosterone           ↑                  Androgen metabolism         Dhayat et al., 2018   GC-MS
  Androstenediol                          ↑                  Androgen metabolism         Dhayat et al., 2018   GC-MS
  Testosterone                            ↑                  Androgen metabolism         Dhayat et al., 2018   GC-MS
  5α-DH-testosterone                      ↑                  Androgen metabolism         Dhayat et al., 2018   GC-MS
  Androstanediol                          ↑                  Androgen metabolism         Dhayat et al., 2018   GC-MS
  Androsterone                            ↑                  Androgen metabolism         Dhayat et al., 2018   GC-MS
  11β-OH-androsterone                     ↑                  Androgen metabolism         Dhayat et al., 2018   GC-MS
  Etiocholanolone                         ↑                  Androgen metabolism         Dhayat et al., 2018   GC-MS
  Estriol                                 ↓                  Estrogen metabolism         Dhayat et al., 2018   GC-MS
  Suberic acid                            ↑                  Fatty acid metabolism       Zou et al., 2018      GC-MS
  3,4,5-hydroxyvaleric acid               ↑                  Fatty acid metabolism       Zou et al., 2018      GC-MS
  (R)-3-Hydroxy-hexadecanoic acid         ↓                  Fatty acid metabolism       Wang et al., 2015     LC-MS
  6-Keto-decanoylcarnitine                ↓                  Fatty acid esters           Wang et al., 2015     LC-MS
  Tiglylcarnitine                         ↑                  Fatty acid esters           Wang et al., 2015     LC-MS
  Butyrylcarnitine                        ↑                  Fatty acid esters           Wang et al., 2015     LC-MS
  4-hydroxyphenylacetic acid              ↑                  Tyrosine metabolism         Zou et al., 2018      GC-MS
  Capryloylglycine                        ↓                  Amino acid metabolism       Wang et al., 2015     LC-MS
  *N*-(7-Isocucurbinoyl)isoleucine        ↑                  Amino acid metabolism       Wang et al., 2015     LC-MS
  Aspartylglycosamine                     ↑                  Amino acid metabolism       Wang et al., 2015     LC-MS
  α-ketoglutarate                         ↑                  Amino acid metabolism       Zou et al., 2018      GC-MS
  Threonine                               ↑                  Amino acid metabolism       Zou et al., 2018      GC-MS
  Serine                                  ↑                  Amino acid metabolism       Zou et al., 2018      GC-MS
  Glycine                                 ↑                  Amino acid metabolism       Zou et al., 2018      GC-MS
  5-Oxoproline                            ↑                  Amino acid metabolism       Zou et al., 2018      GC-MS
  Benzoylglycine                          ↑                  Amino acid metabolism       Zou et al., 2018      GC-MS
  Indoleacetyl glutamine                  ↓                  Aromatic Amino acids        Wang et al., 2015     LC-MS
  Flazine methyl ether                    ↓                  Aromatic Amino acids        Wang et al., 2015     LC-MS
  Succinyladenosine                       ↑                  Aromatic Amino acids        Wang et al., 2015     LC-MS
  Thyronine                               ↑                  Aromatic Amino acids        Wang et al., 2015     LC-MS
  Gamma-glutamyl-leucine                  ↓                  Peptides                    Wang et al., 2015     LC-MS
  Tryptophyl-proline                      ↓                  Peptides                    Wang et al., 2015     LC-MS
  Methionyl-phenylalanine                 ↑                  Peptides                    Wang et al., 2015     LC-MS
  Phenylalanyl-histidine                  ↑                  Peptides                    Wang et al., 2015     LC-MS
  Arginyl-valiney                         ↑                  Peptides                    Wang et al., 2015     LC-MS
  Threoninyl-lysine                       ↑                  Peptides                    Wang et al., 2015     LC-MS
  Tryptophyl-arginine                     ↑                  Peptides                    Wang et al., 2015     LC-MS
  Tyrosyl-leucine                         ↑                  Peptides                    Wang et al., 2015     LC-MS
  Tryptophyl-valine                       ↑                  Peptides                    Wang et al., 2015     LC-MS
  Cis-aconitic acid                       ↑                  CTA metabolism              Zou et al., 2018      GC-MS
  3-Hydroxy-3-Methylglutaric acid         ↑                  Energy metabolism           Zou et al., 2018      GC-MS
  2-Hydroxyglutaric acid                  ↑                  Energy metabolism           Zou et al., 2018      GC-MS
  Threonic acid                           ↑                  Sugar acids metabolism      Zou et al., 2018      GC-MS
  Inosine                                 ↑                  Purine metabolism           Zou et al., 2018      GC-MS
  2,3,4-Hydroxybutyric acid               ↑                  Energy metabolism           Zou et al., 2018      GC-MS
  3,4-Hydroxybutyric acid                 ↑                  Energy metabolism           Zou et al., 2018      GC-MS
  4-Hydroxybutyric acid                   ↑                  Energy metabolism           Zou et al., 2018      GC-MS
  2-Hydroxyisobutyric acid                ↑                  Energy metabolism           Zou et al., 2018      GC-MS
  Uracil                                  ↑                  Pyrimidine metabolism       Zou et al., 2018      GC-MS
  Glyceryl acid                           ↑                  Hydroxy acid metabolism     Zou et al., 2018      GC-MS
  Glycolic acid                           ↑                  Hydroxy acid metabolism     Zou et al., 2018      GC-MS
  2-Hydroxyisobutyric acid                ↑                  Energy metabolism           Zou et al., 2018      GC-MS
  Succinic acid                           ↓                  Glucose metabolism          Zou et al., 2018      GC-MS
  Benzophenone                            ↑                  Acetophenones               Wang et al., 2015     LC-MS
  5′-Carboxy-γ-chromanol                  ↓                  Benzopyrans                 Wang et al., 2015     LC-MS
  5′-Carboxy-α-chromanol                  ↓                  Benzopyrans                 Wang et al., 2015     LC-MS
  9′-Carboxy-α-chromanol                  ↓                  Benzopyrans                 Wang et al., 2015     LC-MS
  11′-Carboxy-α-tocotrienol               ↓                  Benzopyrans                 Wang et al., 2015     LC-MS
  FMNH2                                   ↑                  Pteridines                  Wang et al., 2015     LC-MS
  Urobilin                                ↓                  Tetrapyrroles               Wang et al., 2015     LC-MS
  Mesobilirubinogen                       ↓                  Tetrapyrroles               Wang et al., 2015     LC-MS
  Harderoporphyrinogen                    ↓                  Tetrapyrroles               Wang et al., 2015     LC-MS
  MG (18:4(6Z,9Z,12Z,15Z)/0:0/0:0)        ↑                  Lineolic acids              Wang et al., 2015     LC-MS
  Hydroxyvalerylcarnitine                 ↑                  Alkylamines                 Wang et al., 2015     LC-MS
  Labadoside                              ↑                  Glycosides                  Wang et al., 2015     LC-MS
  Dihydrocaffeic acid 3-O-glucuronide     ↓                  Sugar acids                 Wang et al., 2015     LC-MS
  Dihydroferulic acid 4-O-glucuronide     ↓                  Sugar acids                 Wang et al., 2015     LC-MS
  5-Hydroxy-6-methoxyindole glucuronide   ↑                  Sugar acids                 Wang et al., 2015     LC-MS
  p-Cresol glucuronide                    ↓                  Sugar acids                 Wang et al., 2015     LC-MS
  6β-OH-cortisol                          ↑                  Glucocorticoid metabolism   Dhayat et al., 2018   GC-MS
  18-OH-cortisol                          ↑                  Glucocorticoid metabolism   Dhayat et al., 2018   GC-MS
  TH-cortisol                             ↑                  Glucocorticoid metabolism   Dhayat et al., 2018   GC-MS
  11β-OH-etiocholanolone                  ↑                  Glucocorticoid metabolism   Dhayat et al., 2018   GC-MS
  TH-cortisone                            ↑                  Glucocorticoid metabolism   Dhayat et al., 2018   GC-MS

TG = triglyceride, DG = diglyceride, PC = phosphatidylcholine, (LysoPC) = lysophosphatidylcholine, LPA = lysophosphatidic acid, FMNH2 = reduced flavin mononucleotide; ↑ up-regulation; ↓ down-regulation.
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The most significant changes in FF metabolites in women with PCOS in comparison with the control subjects.

  Metabolites                                                                PCOS vs. Control    Metabolic Pathways                 Studies              Techniques
  -------------------------------------------------------------------------- ------------------- ---------------------------------- -------------------- ------------
  Paxilline                                                                  $\downarrow$        Naphthopyrans                      Liu et al., 2018     LC-MS
  PC (o-22:0/20:4(8Z,11Z,14Z,17Z))                                           $\downarrow$        Glycerophospholipid                Liu et al., 2018     LC-MS
  PC (o22:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))                                     $\downarrow$        Glycerophospholipid                Liu et al., 2018     LC-MS
  LysoPC (16:1(9Z))                                                          $\uparrow$          Glycerophospholipid                Liu et al., 2018     LC-MS
  LysoPC (16:0)                                                              $\uparrow$          Glycerophospholipid                Liu et al., 2018     LC-MS
  Sun et al., 2019                                                           LC-MS                                                                       
  LysoPC (14:0)                                                              $\uparrow$          Glycerophospholipid                Sun et al., 2019     LC-MS
  LysoPC (18:0)                                                              $\uparrow$          Glycerophospholipid                Sun et al., 2019     LC-MS
  LysoPC (20:4(8Z,11Z,14Z,17Z))                                              $\uparrow$          Glycerophospholipid                Liu et al., 2018     LC-MS
  PGP (16:0/20:4(5Z,8Z,11Z,14Z)                                              $\downarrow$        Glycerophospholipid                Liu et al., 2018     LC-MS
  Glycerophosphocholine                                                      $\uparrow$          Glycerophospholipid                Chen et al., 2020    LC-MS
  Ceramide (d18:0/16:0)                                                      $\downarrow$        Sphingolipids                      Liu et al., 2018     LC-MS
  Ceramide (d18:0/24:0)                                                      $\downarrow$        Sphingolipids                      Liu et al., 2018     LC-MS
  Galabiosylceramide (d18:1/24:1(15Z))                                       $\downarrow$        Sphingolipids                      Liu et al., 2018     LC-MS
  Tetrahexosylceramide (d18:1/24:0)                                          $\downarrow$        Sphingolipids                      Liu et al., 2018     LC-MS
  7β-Hydroxycholesterol                                                      $\downarrow$        Lipid metabolism                   Chen et al., 2020    LC-MS
  Malyl-CoA                                                                  $\downarrow$        Fatty Acyls                        Liu et al., 2018     LC-MS
  1-Hydroxy-2,12,15-heneicosatrien-4-one                                     $\uparrow$          Fatty Acyls                        Liu et al., 2018     LC-MS
  16-hydroxypalmitic acid                                                    $\downarrow$        Fatty Acyls                        Liu et al., 2018     LC-MS
  Tridecanol                                                                 $\downarrow$        Fatty Acyls                        Liu et al., 2018     LC-MS
  Carnitine                                                                  $\uparrow$          Fatty acids metabolism             Chen et al., 2020    LC-MS
  4-Hydroxy-3-(16-methylheptadecyl)-2H-pyran-2-one                           $\downarrow$        Pyrans                             Liu et al., 2018     LC-MS
  Anandamide                                                                 $\downarrow$        Organonitrogen compounds           Liu et al., 2018     LC-MS
  Indan-1-ol                                                                 $\uparrow$          Indanes                            Liu et al., 2018     LC-MS
  2-p-Tolyl-1-propene, p-Mentha-1,3,5,8-tetraene                             $\uparrow$          Phenylpropenes                     Liu et al., 2018     LC-MS
  β -Ionol                                                                   $\downarrow$        Sesquiterpenoids                   Liu et al., 2018     LC-MS
  Androstenol                                                                $\downarrow$        Androstane steroids                Liu et al., 2018     LC-MS
  (3R, 6′Z)-3,4-Dihydro-8-hydroxy-3-(6-pentadecenyl)-1H-2-benzopyran-1-one   $\downarrow$        Benzopyrans                        Liu et al., 2018     LC-MS
  6-Tridecylsalicylic acid                                                   $\downarrow$        Benzoic acids and derivatives      Liu et al., 2018     LC-MS
  2,3-dihydroxypropyl dodecanoate                                            $\uparrow$          Glycerol metabolism                Chen et al., 2020    LC-MS
  Methylmalonic acid                                                         $\downarrow$        Carboxylic acids                   Liu et al., 2018     LC-MS
  Lysyl-Valine                                                               $\downarrow$        Carboxylic acids and derivatives   Liu et al., 2018     LC-MS
  Prolyl-Methionine                                                          $\downarrow$        Carboxylic acids and derivative    Liu et al., 2018     LC-MS
  VPGPR Enterostatin                                                         $\downarrow$        Carboxylic acids and derivative    Liu et al., 2018     LC-MS
  1H-Indol-3-ylacetyl-myo-inositol                                           $\downarrow$        Indoles and derivatives            Liu et al., 2018     LC-MS
  1-Pentadecene                                                              $\downarrow$        Unsaturated hydrocarbons           Liu et al., 2018     LC-MS
  Lithocholic acid glycine conjugate                                         $\downarrow$        Non classified                     Liu et al., 2018     LC-MS
  Lactate                                                                    $\downarrow$        Gluconeogenesis/Glycolysis         Zhang et al., 2017   NMR
  $\downarrow$                                                               Liu el al., 2018    GC-MS                                                   
  Glyceraldehyde                                                             $\uparrow$          Gluconeogenesis/Glycolysis         Chen et al., 2020    LC-MS
  Pyruvate                                                                   $\downarrow$        Glucose glycolysis                 Zhang et al., 2017   NMR
  $\uparrow$                                                                 Zhao et al., 2015   GC-MS                                                   
  Valine                                                                     $\uparrow$          Amino acid metabolism              Zhao et al., 2015    MS/MS
  Isoleucine                                                                 $\uparrow$          Amino acid metabolism              Zhao et al., 2015    MS/MS
  Leucine                                                                    $\uparrow$          Amino acid metabolism              Zhao et al., 2015    MS/MS
  Sun et al., 2019                                                           LC-MS                                                                       
  Alanine                                                                    $\downarrow$        Amino acid metabolism              Zhang et al., 2017   NMR
  Glutamine                                                                  $\downarrow$        Amino acid metabolism              Zhang et al., 2017   NMR
  Tyrosine                                                                   $\downarrow$        Amino acid metabolism              Zhang et al., 2017   NMR
  Phenylalanine                                                              $\uparrow$          Amino acid metabolism              Sun et al., 2019     LC-MS
  [d]{.smallcaps}-Glutamic acid                                              $\uparrow$          Amino acid metabolism              Chen et al., 2020    LC-MS
  Ferulic acid                                                               $\uparrow$          Amino acid metabolism              Chen et al., 2020    LC-MS
  Salicylic acid                                                             $\uparrow$          Amino acid metabolism              Chen et al., 2020    LC-MS
  Lysine                                                                     $\uparrow$          Amino acid metabolism              Chen et al., 2020    LC-MS
  3-Methylhistidine                                                          $\uparrow$          Amino acid metabolism              Chen et al., 2020    LC-MS
  α-Keto-β-methylvalerate                                                    $\uparrow$          Alpha-keto acids                   Zhao et al., 2015    GC-MS
  α-Ketoisovalerate                                                          $\uparrow$          Alpha-keto acids                   Zhao et al., 2015    GC-MS
  α-Ketoisocaproate                                                          $\uparrow$          Alpha-keto acids                   Zhao et al., 2015    GC-MS
  Hexanoyl (C6)                                                              $\downarrow$        Acylcarnitines                     Zhao et al., 2015    MS/MS
  Malonyl (C3DC)                                                             $\downarrow$        Acylcarnitines                     Zhao et al., 2015    MS/MS
  Hydroxyisovaleryl (C5OH)                                                   $\downarrow$        Acylcarnitines                     Zhao et al., 2015    MS/MS
  Octenoyl (C8:1)                                                            $\downarrow$        Acylcarnitines                     Zhao et al., 2015    MS/MS
  Adipyl (C6DC)                                                              $\downarrow$        Acylcarnitines                     Zhao et al., 2015    MS/MS
  β-Hydroxybutyrate                                                          $\uparrow$          Ketones                            Zhao et al., 2015    GC-MS
  Succinate                                                                  $\uparrow$          TCA cycle metabolites              Zhao et al., 2015    GC-MS
  Malate                                                                     $\uparrow$          TCA cycle metabolites              Zhao et al., 2015    GC-MS
  Oxaloacetate                                                               $\uparrow$          TCA cycle metabolites              Zhao et al., 2015    GC-MS
  Cis-aconitate                                                              $\downarrow$        TCA cycle metabolites              Zhao et al., 2015    GC-MS
  Acetate                                                                    $\uparrow$          TCA cycle metabolites              Zhang et al., 2017   NMR
  Acetoacetate                                                               $\uparrow$          TCA cycle metabolites              Zhang et al., 2017   NMR
  3-Hyroxybutyrate                                                           $\uparrow$          TCA cycle metabolites              Zhang et al., 2017   NMR
  *N*-Methylnicotinamide                                                     $\downarrow$        Metabolites of NAD catabolism      Zhao et al., 2015    LC-MS/MS
  N1-Methyl-2-pyridone-5-carboxamide (2PY)                                   $\downarrow$        Metabolites of NAD catabolism      Zhao et al., 2015    LC-MS/MS
  N1-Methyl-4-pyridone-3-carboxamide (4PY)                                   $\downarrow$        Metabolites of NAD catabolism      Zhao et al., 2015    LC-MS/MS
  Deoxycorticosterone                                                        $\uparrow$          Steroid metabolism                 Sun et al., 2019     LC-MS
  Pregnenolone                                                               $\downarrow$        Steroid metabolism                 Chen et al., 2020    LC-MS
  17-Hydroxyprogesterone                                                     $\downarrow$        Steroid metabolism                 Chen et al., 2020    LC-MS
  3-Hydroxynonanoyl carnitine                                                $\uparrow$          Fatty acid metabolism              Sun et al., 2019     LC-MS
  Eicosapentaenoic acid                                                      $\uparrow$          Fatty acid metabolism              Sun et al., 2019     LC-MS
  Phytosphingosine                                                           $\downarrow$        Sphingolipid metabolism            Sun et al., 2019     LC-MS
  *N*-acetylneuraminic acid                                                  $\uparrow$          Sialic acid metabolism             Chen et al., 2020    LC-MS
  Pyridoxal 5′-phosphate                                                     $\uparrow$          Vitamin B6 metabolism              Chen et al., 2020    LC-MS
  Purine                                                                     $\uparrow$          Purines metabolism                 Chen et al., 2020    LC-MS
  1,3-Dimethyluracil                                                         $\uparrow$          Purines metabolism                 Chen et al., 2020    LC-MS
  Oxalic acid                                                                $\uparrow$          Glyoxylic acid metabolism          Chen et al., 2020    LC-MS
  Phenylglyoxylic acid                                                       $\uparrow$          Glyoxylic acid metabolism          Chen et al., 2020    LC-MS

PC = phosphatidylcholine, (LysoPC) = lysophosphatidylcholine, PGP = glycerol-3-phosphate, CoA = coenzyme A; ↑ up-regulation; ↓ down-regulation.
